Aptamers for Targeted Therapy

Ge Yang; Yuanyu Huang

doi:10.1007/978-981-33-4838-7_6

Aptamers for Targeted Therapy

Ge Yang
, Yuanyu Huang^*

^*此作品的通讯作者

Beijing Institute of Technology

科研成果: 书/报告/会议事项章节 › 章节 › 同行评审

摘要

This chapter introduces the aptamers for targeted therapy. Aptamers show promising efficacy and safety in four types of clinical studies of ophthalmopathy, blood coagulation, inflammation, and cancer, and there are increasing numbers of evidences to prove the clinical application potential of aptamers. To date, more than a dozen aptamers have entered clinical trials as therapeutic agents for targeted therapy. This chapter introduces their pharmacological development and optimization processes and reviews potential treatment of diseases.

源语言	英语
主期刊名	Aptamers for Medical Applications
主期刊副标题	From Diagnosis to Therapeutics
出版商	Springer Singapore
页	129-178
页数	50
ISBN（电子版）	9789813348387
ISBN（印刷版）	9789813348370
DOI	https://doi.org/10.1007/978-981-33-4838-7_6
出版状态	已出版 - 1 1月 2021
已对外发布	是

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

可持续发展目标 3 良好健康与福祉

访问文件

10.1007/978-981-33-4838-7_6

其它文件与链接

链接到 Scopus 的出版物

引用此

@inbook{2ea265fc4fbd4d85b5af82cb712fe3eb,

title = "Aptamers for Targeted Therapy",

abstract = "This chapter introduces the aptamers for targeted therapy. Aptamers show promising efficacy and safety in four types of clinical studies of ophthalmopathy, blood coagulation, inflammation, and cancer, and there are increasing numbers of evidences to prove the clinical application potential of aptamers. To date, more than a dozen aptamers have entered clinical trials as therapeutic agents for targeted therapy. This chapter introduces their pharmacological development and optimization processes and reviews potential treatment of diseases.",

keywords = "Aptamers, Cancer, Coagulation, Inflammation, Oculopathy, Target therapy",

author = "Ge Yang and Yuanyu Huang",

note = "Publisher Copyright: {\textcopyright} Springer Nature Singapore Pte Ltd. 2021.",

year = "2021",

month = jan,

day = "1",

doi = "10.1007/978-981-33-4838-7\_6",

language = "English",

isbn = "9789813348370",

pages = "129--178",

booktitle = "Aptamers for Medical Applications",

publisher = "Springer Singapore",

address = "Singapore",

}

TY - CHAP

T1 - Aptamers for Targeted Therapy

AU - Yang, Ge

AU - Huang, Yuanyu

N1 - Publisher Copyright: © Springer Nature Singapore Pte Ltd. 2021.

PY - 2021/1/1

Y1 - 2021/1/1

N2 - This chapter introduces the aptamers for targeted therapy. Aptamers show promising efficacy and safety in four types of clinical studies of ophthalmopathy, blood coagulation, inflammation, and cancer, and there are increasing numbers of evidences to prove the clinical application potential of aptamers. To date, more than a dozen aptamers have entered clinical trials as therapeutic agents for targeted therapy. This chapter introduces their pharmacological development and optimization processes and reviews potential treatment of diseases.

AB - This chapter introduces the aptamers for targeted therapy. Aptamers show promising efficacy and safety in four types of clinical studies of ophthalmopathy, blood coagulation, inflammation, and cancer, and there are increasing numbers of evidences to prove the clinical application potential of aptamers. To date, more than a dozen aptamers have entered clinical trials as therapeutic agents for targeted therapy. This chapter introduces their pharmacological development and optimization processes and reviews potential treatment of diseases.

KW - Aptamers

KW - Cancer

KW - Coagulation

KW - Inflammation

KW - Oculopathy

KW - Target therapy

UR - https://www.scopus.com/pages/publications/85150585355

U2 - 10.1007/978-981-33-4838-7_6

DO - 10.1007/978-981-33-4838-7_6

M3 - Chapter

AN - SCOPUS:85150585355

SN - 9789813348370

SP - 129

EP - 178

BT - Aptamers for Medical Applications

PB - Springer Singapore

ER -

Aptamers for Targeted Therapy

摘要

联合国可持续发展目标

访问文件

其它文件与链接

学术指纹

引用此